where N is the number of experimental data points, x A cal is the correlated solubility, and x A is the experimental solubility of the solute in the binary solvent mixtures. The basic Jouyban−Acree model for representing the solubility of drugs in binary solvent mixtures at various temperatures is 
where x B 0 and x C 0 are the mass fractions of solvents B (water) and C (methanol, ethanol, or glycol) in the absence of the solute, (x A ) B,T and (x A ) C,T are the mole fraction solubilities of the solute in the monosolvents B and C, T is the absolute temperature, and the J i terms are the model constants computed using a no-intercept least-squares analysis. 2 It is possible to replace x C 0 by (1 − x B 0 ) in eq 2, and with n = 2 the equation can be rearranged as 
The ln(x A ) B,T and ln(x A ) C,T could be replaced with the corresponding values from a semiempirical model 4 as
By combination of eqs 3, 4, and 5 and further rearrangements, Zhou et al. obtained The van't Hoff equation is applicable to the ideal solutions, and in case of real pharmaceutical solutions, it is possible to use eq 4 when nonlinear van't Hoff plot is obtained. 4 The basic Jouyban−Acree model has been employed in a number of recent reports by replacing the solubility of the solute in monosolvents, that is, ln(x A ) B,T and ln(x A ) C,T , with the corresponding values from the van't Hoff equation and produced reasonably accurate results. 5−7 In these works, we expressed the variation in ln(x A ) B,T and ln(x A ) C,T values in eq 2 as
Equation 8 was used to correlate the solubility of (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid in three investigated solvent systems, and the model constants and the MPD values are listed in Table 1 . The overall MPDs of eqs 6 and 8 are 4.2 and 4.5, and relatively the same accuracies were obtained for correlated data using both models. It should be noted that eq 8 contains two fewer adjustable curve-fit coefficients and that some of the model constants of eq 6 possess a higher probability (p > 0.10), revealing that these constants are not statistically significant. We also note that eq 8 can be trained using a minimum number of experimental data points and then be used to predict the solubility at other solvent compositions and temperatures of interest. To illustrate this application of the model, it has been trained using seven data points (two data points of solvent B at the highest and lowest temperatures, the same data points for solvent C, and three data points with different solvent compositions of the binary solvent), and then the remaining solubility data points were predicted using an interpolation technique. The obtained MPDs for aqueous mixtures of methanol, ethanol, and glycol were 10.6 (N = 73), 17.7 (73), and 14.8 (N = 103), respectively, with the overall being 14.4. To compare similar data predicted by eqs 6 and 8, both models were trained using 10 experimental data points (two data points of solvent B at the highest and lowest temperatures, the same data points for solvent C, and six data points with different solvent compositions of the binary solvent), and the rest of data points were predicted using the trained models. The obtained MPDs for aqueous mixtures of methanol, ethanol, and glycol for eq 6 were 5.8 (N = 70), 5.5 (70), and 5.5 (N = 100), respectively, with the overall 5.6. The corresponding values for eq 8 were 5.7 (N = 70), 5.6 (70), and 5.7 (N = 100), respectively, with the overall 5.7.
The main advantages that the Jouyban−Acree model has over the derived version for representing the solubility of solutes in binary solvent mixtures are: (1) a more accurate correlation of the solubility of drugs in binary solvents at various temperatures among similar algorithms employing equal number of curve-fitting parameters, (2) the prediction of the solubility using a minimum number of experimental data points with an acceptable prediction error, (3) theoretical justification of the model constants, 8 (4) a uniform mathematical representation of solubility and other physicochemical properties, (5) the calculated equation coefficients for binary solvent mixtures which can be combined to estimate solute solubility in ternary and higher-order multicomponent systems, 9 and (6) the availability of the globally trained versions of the model to predict the solubility of pharmaceuticals in mixed solvents at various temperatures employing the solubility data in monosolvents. 10−12 Concerning these advantages, the results of testing the model on a large number of data sets examined, and the ease of the required calculations, it is recommended for use in the correlation and/or prediction of the solubility of pharmaceuticals in mixed solvents.
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